PNC Financial Services Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.2B Sell
51,328,908
-4,312
-0% -$4.37M 27.26% 1
2025
Q4
$55.2B Sell
51,333,220
-30,969
-0.1% -$29.6M 30.13% 1
2025
Q3
$39.2B Buy
51,364,189
+70,209
+0.1% +$52.2M 23.77% 1
2025
Q2
$40B Sell
51,293,980
-50,011,670
-49% -$38.9B 25.77% 1
2025
Q1
$83.7B Buy
101,305,650
+50,002,551
+97% +$41.6B 43.81% 1
2024
Q4
$39.6B Sell
51,303,099
-57,631
-0.1% -$47.7M 26.48% 1
2024
Q3
$45.5B Sell
51,360,730
-44,106
-0.1% -$39.7M 29.04% 1
2024
Q2
$46.5B Sell
51,404,836
-33,360
-0.1% -$26.7M 30.99% 1
2024
Q1
$40B Sell
51,438,196
-271,277
-0.5% -$193M 27.82% 1
2023
Q4
$30.1B Sell
51,709,473
-79,818
-0.2% -$46.6M 23.68% 1
2023
Q3
$27.8B Sell
51,789,291
-80,514
-0.2% -$41.5M 23.81% 1
2023
Q2
$24.3B Sell
51,869,805
-52,135
-0.1% -$21.9M 20.72% 1
2023
Q1
$17.8B Sell
51,921,940
-114,183
-0.2% -$38.5M 15.64% 1
2022
Q4
$19B Sell
52,036,123
-3,979
-0% -$1.41M 18.28% 1
2022
Q3
$16.8B Sell
52,040,102
-51,980
-0.1% -$16.5M 17.59% 1
2022
Q2
$16.9B Sell
52,092,082
-53,782
-0.1% -$16.1M 16.57% 1
2022
Q1
$14.9B Buy
52,145,864
+29,909
+0.1% +$7.7M 13.09% 1
2021
Q4
$14.4B Sell
52,115,955
-6,141
-0% -$1.56M 11.9% 1
2021
Q3
$12B Sell
52,122,096
-81,895
-0.2% -$20.2M 11.14% 1
2021
Q2
$12B Sell
52,203,991
-4,863
-0% -$977K 10.86% 1
2021
Q1
$9.75B Sell
52,208,854
-124,642
-0.2% -$24.4M 9.47% 1
2020
Q4
$8.84B Buy
52,333,496
+49,978,267
+2,122% +$7.46B 8.92% 1
2020
Q3
$349M Sell
2,355,229
-39,961
-2% -$6.18M 0.43% 54
2020
Q2
$393M Sell
2,395,190
-56,819
-2% -$8.72M 0.52% 46
2020
Q1
$340M Buy
2,452,009
+67,596
+3% +$9.29M 0.43% 48
2019
Q4
$313M Buy
2,384,413
+96,038
+4% +$11.1M 0.31% 74
2019
Q3
$256M Sell
2,288,375
-37,938
-2% -$4.22M 0.26% 86
2019
Q2
$258M Sell
2,326,313
-70,636
-3% -$8.32M 0.25% 86
2019
Q1
$311M Buy
2,396,949
+41,525
+2% +$5.05M 0.31% 70
2018
Q4
$273M Buy
2,355,424
+124,751
+6% +$13.9M 0.3% 71
2018
Q3
$239M Buy
2,230,673
+658,607
+42% +$65.8M 0.23% 91
2018
Q2
$134M Sell
1,572,066
-12,213
-0.8% -$1M 0.13% 137
2018
Q1
$123M Sell
1,584,279
-156,113
-9% -$12.6M 0.12% 147
2017
Q4
$147M Buy
1,740,392
+23,049
+1% +$1.96M 0.14% 132
2017
Q3
$147M Sell
1,717,343
-16,666
-1% -$1.37M 0.15% 126
2017
Q2
$143M Sell
1,734,009
-52,629
-3% -$4.29M 0.15% 132
2017
Q1
$150M Sell
1,786,638
-31,545
-2% -$2.53M 0.17% 122
2016
Q4
$134M Sell
1,818,183
-109,066
-6% -$8.12M 0.15% 132
2016
Q3
$155M Sell
1,927,249
-192,902
-9% -$15.4M 0.18% 117
2016
Q2
$167M Sell
2,120,151
-66,259
-3% -$4.99M 0.2% 104
2016
Q1
$157M Sell
2,186,410
-81,826
-4% -$6.19M 0.18% 114
2015
Q4
$191M Buy
2,268,236
+45,936
+2% +$3.81M 0.23% 94
2015
Q3
$186M Sell
2,222,300
-156,584
-7% -$13.2M 0.22% 89
2015
Q2
$199M Sell
2,378,884
-38,125
-2% -$2.9M 0.22% 85
2015
Q1
$176M Buy
2,417,009
+29,414
+1% +$2.09M 0.19% 102
2014
Q4
$165M Sell
2,387,595
-28,578
-1% -$1.93M 0.18% 104
2014
Q3
$157M Buy
2,416,173
+728,972
+43% +$46.2M 0.18% 95
2014
Q2
$105M Sell
1,687,201
-26,436
-2% -$1.58M 0.13% 129
2014
Q1
$101M Buy
1,713,637
+24,937
+1% +$1.39M 0.13% 125
2013
Q4
$86.1M Sell
1,688,700
-19,331
-1% -$968K 0.11% 140
2013
Q3
$86M Buy
1,708,031
+41,832
+3% +$2.19M 0.13% 141
2013
Q2
$81.8M Buy
+1,666,199
New +$90.7M 0.12% 139

Other funds holding LLY

PNC Financial Services Group's LLY Position: Q1 2026 in Review

PNC Financial Services Group reduced its Eli Lilly (LLY) stake by 0.01% in Q1 2026, selling an estimated $4.37M and leaving 51,328,908 shares worth $47.2B. The position accounts for 27.26% of the portfolio, ranked #1.

PNC Financial Services Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $83.7B in Q1 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • PNC Financial Services Group held 51,328,908 shares of Eli Lilly worth $47.2B as of Q1 2026.
  • PNC Financial Services Group sold 4,312 Eli Lilly shares in Q1 2026, an estimated $4.37M.
  • Eli Lilly made up 27.26% of PNC Financial Services Group's portfolio in Q1 2026, its #1 holding.
  • PNC Financial Services Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Eli Lilly position peaked at $83.7B in Q1 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.